中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
24期
3-4,5
,共3页
米索前列醇%羊膜腔外引产%依沙丫啶%米非司酮
米索前列醇%羊膜腔外引產%依沙丫啶%米非司酮
미색전렬순%양막강외인산%의사아정%미비사동
Misoprostol%Extra-amniotic cavity%Rivanol%Mifepristone
目的:探讨不同引产方式用于终止12~15周妊娠的临床效果。方法:将170例停经12~15周孕妇需要终止妊娠者随机分为三组。A组60例,米索前列醇联合利凡诺羊膜腔外引产;B组57例,口服米非司酮及阴道放置米索前列醇药物引产;C组53例,利凡诺羊膜腔外引产。结果:A、B组单次引产成功率明显高于C组,清宫率、产后2 h阴道流血量均低于C组,差异有统计学意义(P<0.05);A组与B组比较,单次引产成功率、阴道流血量差异无统计学意义(P>0.05),B组清宫率低于A组,差异有统计学意义(P<0.05);三组患者均无明显不良反应。结论:米非司酮联合阴道放置米索前列醇用于终止12~15周妊娠引产成功率高,简单、安全、出血少、副作用少,值得临床推广。
目的:探討不同引產方式用于終止12~15週妊娠的臨床效果。方法:將170例停經12~15週孕婦需要終止妊娠者隨機分為三組。A組60例,米索前列醇聯閤利凡諾羊膜腔外引產;B組57例,口服米非司酮及陰道放置米索前列醇藥物引產;C組53例,利凡諾羊膜腔外引產。結果:A、B組單次引產成功率明顯高于C組,清宮率、產後2 h陰道流血量均低于C組,差異有統計學意義(P<0.05);A組與B組比較,單次引產成功率、陰道流血量差異無統計學意義(P>0.05),B組清宮率低于A組,差異有統計學意義(P<0.05);三組患者均無明顯不良反應。結論:米非司酮聯閤陰道放置米索前列醇用于終止12~15週妊娠引產成功率高,簡單、安全、齣血少、副作用少,值得臨床推廣。
목적:탐토불동인산방식용우종지12~15주임신적림상효과。방법:장170례정경12~15주잉부수요종지임신자수궤분위삼조。A조60례,미색전렬순연합리범낙양막강외인산;B조57례,구복미비사동급음도방치미색전렬순약물인산;C조53례,리범낙양막강외인산。결과:A、B조단차인산성공솔명현고우C조,청궁솔、산후2 h음도류혈량균저우C조,차이유통계학의의(P<0.05);A조여B조비교,단차인산성공솔、음도류혈량차이무통계학의의(P>0.05),B조청궁솔저우A조,차이유통계학의의(P<0.05);삼조환자균무명현불량반응。결론:미비사동연합음도방치미색전렬순용우종지12~15주임신인산성공솔고,간단、안전、출혈소、부작용소,치득림상추엄。
Objective:To investigate the clinical effectiveness of different methods in termination of 12-15 weeks of pregnancy.Method:A total of 170 women seeking for terminating 12-15 weeks of gestation were randomly divided into three groups,group A(n=60,Misoprostol combined with extra-amniotic cavity injection of Rivanol),group B(n=57,Mifepristone combined with vaginal Misoprostol),group C(n=53,extra-amniotic cavity injection of Rivanol).The clinical effectiveness of these three methods was evaluated.Result:Compared with group C,higher success rate of labor induction,lower rate of post-abortion curettage, less amount of vaginal bleeding were found in group A and group B(P<0.05).Compared with group A,lower rate of post-abortion curettage was observed in group B, there were no significant differences in the success rate of labor induction and amount of vaginal bleeding between group A and group B.There were no significant adverse reactions among three groups.Conclusion:Mifepristone combined with vaginal Misoprostol in termination of 12-15 weeks of pregnancy are high success rate,simple,safe,small side effect,and worthy of widely clinical.